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Introduction: The purpose of this trial was to investigate the effectiveness of an exercise rehabilitation program
commencing during ICU admission and continuing into the outpatient setting compared with usual care on
physical function and health-related quality of life in ICU survivors.
Methods: We conducted a single-center, assessor-blinded, randomized controlled trial. One hundred and fifty
participants were stratified and randomized to receive usual care or intervention if they were in the ICU for 5 days
or more and had no permanent neurological insult. The intervention group received intensive exercises in the ICU
and the ward and as outpatients. Participants were assessed at recruitment, ICU admission, hospital discharge and
at 3-, 6- and 12-month follow-up. Physical function was evaluated using the Six-Minute Walk Test (6MWT) (primary
outcome), the Timed Up and Go Test and the Physical Function in ICU Test. Patient-reported outcomes were
measured using the Short Form 36 Health Survey, version 2 (SF-36v2) and Assessment of Quality of Life (AQoL)
Instrument. Data were analyzed using mixed models.
Results: The a priori enrollment goal was not reached. There were no between-group differences in demographic
and hospital data, including acuity and length of acute hospital stay (LOS) (Acute Physiology and Chronic Health
Evaluation II score: 21 vs 19; hospital LOS: 20 vs 24 days). No significant differences were found for the primary
outcome of 6MWT or any other outcomes at 12 months after ICU discharge. However, exploratory analyses showed
the rate of change over time and mean between-group differences in 6MWT from first assessment were greater in
the intervention group.
Conclusions: Further research examining the trajectory of improvement with rehabilitation is warranted in this
population.
Trial registration: The trial was registered with the Australian New Zealand Clinical Trials Registry
ACTRN12605000776606.
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Each year in Australia, more than 125,000 patients are
admitted to the ICU, of whom more than 80% survive
[1]. In England, this figure is nearly 240,000 [2]. There is
growing evidence that many survivors experience long-
term physical, neurocognitive and mental health compli-
cations directly associated with their ICU experience.
This has been termed post–intensive care syndrome
(PICS) [3].
The provision of exercise rehabilitation has been advo-
cated to address the weakness and functional limitation
observed in ICU survivors [4-6]. Despite this, only a few
controlled intervention trials have quantified its effect-
iveness beyond hospital discharge [7-9], with one
community-based trial providing follow-up to 6 months
[10]. No study has yet reported the effects of providing
rehabilitation as a continuum from inpatient to out-
patient care and measured outcomes at 12 months after
ICU discharge. To the best of our knowledge, our
present study is the first trial documenting Australian
rehabilitation outcomes that include within-hospital
intervention with 12-month follow-up.
The primary purpose of this study was to assess the
effectiveness of an intensive physiotherapy exercise re-
habilitation program commencing at day 5 after ICU
admission, progressing daily on the acute hospital ward
and being administered twice weekly for 8 weeks in the
outpatient setting, compared with usual care, on phys-
ical function as measured using the Six-Minute Walk
Test (6MWT) at 12 months after ICU discharge. Sec-
ondary aims were to assess differences in function
using the Timed Up and Go (TUG) Test, Physical
Function in ICU Test (PFIT) and health-related quality
of life (HRQoL) at 12 months using both the Assess-
ment of Quality of Life (AQoL) Instrument and the
Short Form 36 Health Survey, version 2 (SF-36v2). A
detailed study protocol has previously been published
and is available online [11]. The specific details of the
physiotherapy intervention have been published else-
where [12], and the results were previously reported in
abstract form [13].
Materials and methods
Human Research Ethics approval was obtained from
Austin Health, Melbourne, Australia. Informed consent
was obtained from the patients or their substitute
decision-makers prior to enrollment, and the trial was
registered with the Australian New Zealand Clinical
Trials Registry (ACTRN12605000776606). The conduct
and reporting of the trial conforms to CONSORT exten-
sion guidelines [14].
We conducted a single-center, stratified, phase II, ran-
domized controlled parallel group trial with assessor
blinding in a 20-bed tertiary ICU in Melbourne,Australia. The hypothesis for the primary aim was that,
compared with patients who receive usual care, patients
who underwent intensive rehabilitation in ICU, hospital
and community settings would demonstrate greater im-
provement in physical function as measured using the
6MWT at 12 months. To be eligible for enrollment,
adult participants had to reside within a 50-km radius of
the hospital; to have no neurological, spinal or musculo-
skeletal dysfunction preventing participation in physical
rehabilitation; and to have an ICU length of stay (LOS)
of at least 5 days. An ICU LOS more than 5 days was
deemed to represent a prolonged ICU stay. This was de-
fined as double the average LOS for ICU survivors in
the previous 18-month period (2.5 days) at Austin
Health, Melbourne (Australian and New Zealand Inten-
sive Care Society (ANZICS) portal [15]. Individual par-
ticipation was agreed upon by the attending intensivist.
Within strata, participants were randomly assigned to
receive either usual care plus exercise rehabilitation or
usual care alone. An independent statistician performed
the randomization by creation of a random numbers
table and use of color-coded (for stratification), opaque,
numbered envelopes. Physiotherapists other than those
who provided usual care performed the trial intervention
across the trial continuum. The outcome assessor was
blinded to group allocation, and the success of blinding
was measured with a short questionnaire at each time
point. The strata were diagnosis classification (medical
or surgical) and mechanical ventilation at day 5 (yes or
no), creating four possible groups.
Usual care
In both groups, physiotherapists provided both respira-
tory and mobility management based upon individual
patient assessment [12] according to unit protocols. Ad-
ministration of intravenous sedation in the ICU was ti-
trated to achieve a Richmond Agitation Sedation Scale
score between −1 and +1 [16] for each patient. In the
usual-care arm, mobility may have included active bed
exercises, sitting out of bed and/or marching or walking.
Usual care was available 7 days per week for 12 hours
per day. Acute ward physiotherapy services emphasized
functional recovery and discharge planning. Outpatient
exercise classes for ICU survivors were not included in
usual-care physiotherapy at the hospital.
Intervention arm
Intervention was individualized based upon participant
level and results of baseline physical function tests [17].
The criteria for safety and ceasing the intervention were
set a priori and published previously in the protocol
paper [11]. An overview of intervention in ICU, on the
acute ward and in outpatients is provided in Table 1 and
the Additional file 1. The intervention was designed to







15 min/day 2 × 15 min/day 2 × 30 min/day progressed to 1 × 60
min/day
60 min twice weekly for 8 wk
Type of exercise Marching in place Cardiovascular, progressive resistance
strength training and functional exercise
Cardiovascular, progressive resistance
strength training and functional exercise
Moving from sitting to standing
Arm and leg active and active
resistance movements
Protocol breach <10 min/session <20 min/session
Repetitions Prescribed from baseline PFIT and
Modified Borg Scale
Prescribed from baseline 6MWT, cycle
ergometer, 5RM
Prescribed from pre-outpatient 6MWT, cycle
ergometer, 5RM
Intensity Target Modified Borg Scale score 3
to 5
Modified Borg Scale score 4 to 6 Modified Borg Scale score 4 to 6
Commenced at 70% peak walking
speed
Commenced at 70% peak walking speed
a5RM, repetition maximum used for strength training; PFIT, Physical Function in the ICU Test; 6MWT, Six-Minute Walk Test. Weaned means successfully weaned
from mechanical ventilation or able to be disconnected from mechanical ventilation for more than 4 hours/day. Weaning from mechanical ventilation was
achieved using a standardized unit weaning protocol.
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physiological principles of exercise prescription, in all
phases of the study than would be received as part of
usual care. The timing of outcomes post hospital dis-
charge are given in Figure 1.
Statistical analyses
The study was designed to enroll 200 patients to provide
a statistical power of 80% to detect a mean difference in
6MWT at 6 months of 50 m using a standard deviation
of 110 m, including allowance for loss to follow-up [18].
All descriptive data were analyzed using SPSS for Win-
dows version 18.0 software (SPSS, Chicago, IL, USA).
Analyses of the outcome data were performed using
SAS for Windows version 9.3 software (SAS Institute,
Inc, Cary, NC, USA). The primary outcome (6MWT)
was analyzed on the basis of a linear mixed model with
group (usual care or intervention) and time (treated as
categorical with levels at ICU discharge, hospital dis-
charge, and 3, 6 and 12 months post–ICU discharge).
Linear mixed models use all data available at each time
point; thus missing data imputation was not undertaken.
Stratification factors (diagnosis classification: medical or
surgical, mechanical ventilation at day 5 yes or no) were
also included as covariates by adding them to the regres-
sion model. A similar approach was used for the second-
ary outcomes (TUG, AQoL and SF-36) and applied to
all available data. Analyses were pragmatic and based on
the intention-to-treat principle, which included data on
all randomized participants with at least one outcome
measure. Analysis of covariance was used to examine
the group difference for PFIT with adjustment for the
stratification factors as well as the baseline measure of
PFIT. The exploratory analysis also used a linear mixedmodel, but with time considered as a continuous term in
the model. This allowed the investigation of the rate of
change between groups.
Descriptive data analysis, individual change scores and
95% confidence intervals were calculated between first
assessment (in ICU for PFIT, prerandomization for
AQoL and SF-36v2 and at ICU discharge or ward arrival
for 6MWT and TUG) and follow-up assessments at ICU
discharge for PFIT and at 3 and 12 months using ob-
served data for the remaining measures. These values
were compared with the minimal clinically important dif-
ference for each outcome. Differences in ICU-acquired
weakness (ICUAW), measured at day 7 postawakening,
between those who were ventilated at day 5 and those
who were not were examined using independent t-tests.
Further details of statistical analyses are available in
Additional file 1.
Results
Participants were recruited from May 2007 until August
2009, with follow-up completed by September 2010. Par-
ticipant flow through the trial is described in Figure 1.
The predetermined sample size goal of 200 was not
achieved. Individuals who consented to participate rep-
resented a cohort of medical and surgical patients with a
moderate illness severity score and a mean age of 60
years who had been admitted to the ICU for 5 days or
more (Table 2). Only 8% were never intubated, and 55%
were still mechanically ventilated (MV) on day 5 after
admission, with a median length of MV of 4 days. Med-
ical diagnoses made up 82 patients (55%) in the sample
population, and 112 (75%) had at least one chronic dis-
ease comorbidity. The acute hospital readmission rate
was 41% in both groups at 12 months. Thirty-four
Excluded n=614
Permanent neuro damage 
n=145
Outside metro area n=132
Refused consent n=122
Spinal cord injury n = 73
Imminent death n=63
Inadequate English n=44
Inability to exercise n=17
Other n=18




Lost to follow-up (n=7) 
Refused (n=4) 




Lost to follow-up (n=2) 
Refused (n = 1) 
3 month Follow-up








(Day 5 in ICU)   
n = 764




Lost to follow-up (n=11)











Lost to follow-up (n=4) 
Refused (n=1)








AnalysisAnalysed n=74 Analysed n=76
up
up
Figure 1 Participant flow through the trial.
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tion, and this was evenly distributed between groups. Of
the subgroup (stratum) that included participants who
remained ventilated at day 5 post–ICU admission, 20
(38%) of 53 met criteria for ICUAW compared with 9
(17%) of 53 of the participants who were not ventilated at
day 5 post–ICU admission, and this difference was signifi-
cant (P = 0.017). However, there were no significant
between-group differences in the incidence of ICUAW
(defined as Medical Research Council score less than 48
of 60) (Table 2). There were no other significant between-
group differences in any of the patient variables.There were no major adverse events during exercise
intervention according to our a priori safety criteria
[11], and overall mortality at 12 months was 32 partici-
pants (21%). A further 36 participants (24%) had with-
drawn or were lost to follow-up at 12 months, 20 (13%)
by the 3-month time point.
Details of blinding and compliance with assessments
(Additional files 2 and 3) are presented in Additional file 1.
Once initiated, the treatment intervention was unable to
be completed in the ICU on 5% of the occasions and on
6% of occasions on the ward. Although no individual
session was unable to be completed in the outpatient
Table 2 Characteristics of trial participantsa
Variable Usual care Intervention
(n = 76) (n = 74)
Mean age (SD) (yr) 60.1 (15.8) 61.4 (15.9)
Gender (% male) 68.4 58.1
Mean BMI (SD) 27.7 (6.1) 27.5 (5.4)




Cardiac surgery 22 23
Other surgery 16 15
Liver disease/transplant 7 14









More than one chronic disease 42 28
28-day mortality (%) 7.9 8.1
12-month mortality (%) 25.0 17.6
ICU LOS (days), median (IQR) 7.0 (6.0 – 11.0) 8.0 (6.0 – 12.0)
ICU LOS ≥10 days (%) 32.0 40.5
Acute LOS (days), median (IQR) 20.0 (13.0-30.8) 23.5 (16.0 - 41.5)
ICUAW (% yes) 17.1 21.6
MV hours, median (IQR) 98.0 (47.5-160.5) 105.0 (52.0-216.5)
MV at day 5, % (n) 55.3 (42) 55.4 (41)
Readmissions, % (n) 40.8 (31) 41.9 (31)
Discharge location
Home % (n) 52.6 (40) 59.5 (44)
Rehabilitation 25.0 (19) 20.3 (15)
Acute hospital 5.3 (4) 5.4 (4)
Other 17.1 (13) 14.9 (11)
aAPACHE II, Acute Physiology and Chronic Health Evaluation II; BMI, body mass
index; ICU LOS, intensive care unit length of stay; ICUAW, intensive care unit–
acquired weakness, measured at 7 days after awakening; IQR, interquartile
range; MV, mechanical ventilation; SD, standard deviation. Readmissions are
defined as acute hospital readmission during the 12-month trial follow-up
period. Discharge locations are defined as rehabilitation = inpatient
rehabilitation, acute hospital = transferred to another acute hospital and
other = palliative care, transitional care or deceased.
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habilitation and 25 (41%) of 61 completed the classes
(more than 70% attendance required). Ten participants
were deceased and three withdrew from the trial priorto commencement of the outpatient program. There
were no statistically significant differences in the demo-
graphics of the 59% who did not complete outpatient
assessments compared with those who did complete
outpatient assessments (see Additional file 4) or the
rest of the sample. Further information related to out-
comes for outpatient noncompleters and completers
can be found in Additional file 4.
The raw descriptive data (Table 3) demonstrate that
both the usual-care and intervention groups improved in
all outcomes up to 12 months. There was a high level of
variability in results, as demonstrated by the size of the
standard deviations presented in Table 3. Compared
with population norms, the 6MWT, TUG, AQoL and
SF-36 results at 12 months remained below predicted
values for age and gender. The 6MWT and AQoL scores
were 60% to 65% of Australian norm-based scores at 12
months [19,20].Physical function performance
There was a difference in 6MWT at the first measure
(ICU discharge). The intervention group walked a sig-
nificantly shorter distance, but there were no significant
differences at any subsequent time point, including at 12
months, based upon the model estimates (Table 4). The
data for the primary outcome measure, 6MWT, are
presented in Figure 2. There were no significant differ-
ences between the groups in TUG improvements at any
time point. Adjusting for the four a priori subgroups
(ventilated or not ventilated at day 5 plus either medical
or surgical condition) did not change outcomes mea-
sured using the 6MWT or TUG (results not shown).
There was no difference between the intervention and
usual-care groups within the ICU in function measured
using the PFIT with mean differences between groups of
−0.3 (95% CI −0.9 to 0.3, P = 0.343).
Although there were no differences between groups at
any time point on the 6MWT, the steeper upward slope
to 3 months of the intervention group shown in Figure 2
demonstrated that the trajectory of recovery may be dif-
ferent for the intervention and control arms of the study;
therefore, we undertook exploratory analyses to describe
these differences over the trial period. Group was a sig-
nificant predictor of rate of change (group × time; P =
0.049), with the intervention group showing greater im-
provement compared with the usual-care group (Table 5).
Between-group differences in mean changes from first as-
sessment to 3 months and 12 months were moderate (ef-
fect size = 0.53 and 0.54, respectively) and greater than the
reported minimal clinically important difference (MCID)
(see Additional file 1), although the confidence intervals
were wide (Table 6) [21,22]. There were no between-
group differences in TUG rate of change (P = 0.072), and
Table 3 Six-Minute Walk Test, Timed Up and Go Test, Physical Function in ICU Test, Assessment of Quality of Life
Instrument utility and Short Form 36 Health Survey, version 2 raw scores by study groupa
Measurement time point








Outcome measure n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)
6MWT (m) Usual care 60 187.9 (126.1) 58 266.7 (136.8) 52 382.1 (139.4) 45 402.4 (166.6) 38 409.6 (158.5)
Intervention 63 146.4 (79.4) 59 244.2 (124.0) 48 384.5 (147.9) 44 394.2 (156.2) 41 433.8 (150.7)
TUG (s) Usual care 60 36.1 (42.9) 57 12.9 (6.6) 53 11.6 (11.2) 48 12.9 (17.9) 40 14.2 (24.7)
Intervention 63 41.1 (43.2) 59 18.8 (24.5) 51 12.2 (10.0) 47 9.8 (5.1) 45 10.3 (6.2)
PFIT Usual care 72 5.2 (3.0) 56 8.0 (1.5)
Intervention 72 5.1 (3.1) 61 7.7 (1.7)
AQoL (utility) Usual care 56 0.6 (0.3) 66 0.5 (0.4) 63 0.6 (0.4) 57 0.5 (0.4)
Intervention 52 0.6 (0.3) 59 0.5 (0.4) 58 0.5 (0.4) 56 0.5 (0.4)
SF-36v2 PF Usual care 56 42.8 (13.1) 52 42.3 (12.0) 48 42.4 (13.7) 38 44.0 (11.2)
Intervention 52 39.6 (15.3) 49 39.9 (14.4) 48 40.1 (14.7) 42 41.4 (12.5)
PCS Usual care 56 41.7 (11.5) 51 42.1 (9.6) 47 44.4 (10.7) 38 46.2 (9.4)
Intervention 51 39.3 (12.9) 49 41.0 (11.4) 47 41.6 (13.2) 42 44.7 (10.9)
MCS Usual care 56 44.3 (12.8) 51 46.3 (12.0) 47 46.2 (12.9) 38 44.7 (15.7)
Intervention 51 41.8 (13.3) 49 46.0 (13.9) 47 45.8 (12.9) 42 47.9 (12.3)
a6MWT, Six-Minute Walk Test (meters), higher scores equal improved performance, normative value = 662 m; TUG, Timed Up and Go Test (seconds), lower scores
equal improved performance, normative value = 9.19 s; PFIT, Physical Function in ICU Test, scored on the basis of Rasch analysis, interval score range 0 to 10, with
higher scores indicating improved performance; AQoL, Assessment of Quality of Life Measure; consistent with utility theory, for those who died, the AQoL utility
score was set at 0.00 and higher scores indicate higher utility; SF-36v2, Short Form 36 Health Survey, version 2, in which higher scores indicate improved
performance; PF, SF-36v2 physical function domain; PCS, SF-36v2 physical component score, MCS, SF-36v2 mental component score. SF-36v2 results are presented
as T-scores where the population mean is 50 and the SD is 10. With the SF-36v2, only survivors at each time point contribute data. Baseline AQoL and SF-36 were
administered to participants as close as possible to enrollment in the trial as a “then test” whereby participants retrospectively estimated their premorbid health-
related quality of life.
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(Table 5).Patient-reported outcomes: health-related quality of life
There were no between-group differences in AQoL util-
ity scores at any time point (Additional file 5), and no
domains of the SF-36v2 demonstrated between-group dif-
ferences at any time point (Additional files 5, 6 and 7).
Adjusting for a priori subgroups (ventilated at day 5 and
medical or surgical) did not change outcomes for HRQoL
measures. Sensitivity analyses involving identification andTable 4 Group comparisons for Six-Minute Walk Test from th
Study visit Usual care
mean 6MWT (SE)
ICU discharge 189.8 (13.6)
Discharge to home 263.4 (16.9)
3 months post–ICU discharge 366.7 (19.7)
6 months post–ICU discharge 394.7 (22.4)
12 months post–ICU discharge 404.9 (23.0)
a6MWT, Six-Minute Walk Test; SE, standard error; CI, confidence interval. Means wer
from the linear mixed model. Subject numbers are the same as those reported in Tremoval of outliers did not markedly alter the results
presented herein (data not shown).Discussion
Our research presented herein is the first to assess the
effectiveness of a continuum of physiotherapy-led re-
habilitation from the ICU through outpatient rehabilita-
tion with 12-month follow-up in a mixed medical and
surgical population in Australia. Primary outcomes ana-
lysis based upon differences in 6MWT results showed
no significant differences between study groups at 12e model estimatesa
Intervention Mean difference from usual care
mean 6MWT (SE) (95% CI, P value)
145.1 (13.3) −44.7 (−82.3 to −7.1, 0.020)
241.9 (16.6) −21.5 (−68.4 to 25.4, 0.365)
382.2 (19.9) 15.4 (−40.1 to 71, 0.583)
389.9 (22.6) −4.9 (−68.0 to 58.3, 0.879)
409.6 (22.9) 4.7 (−59.7 to 69.2, 0.884)
e calculated and comparisons between groups were made at each time point
able 3. Values given are in meters.
Figure 2 Mean Six-Minute Walk Test (standard error) by study group calculated from model estimates. Note that the calculated
population mean for this sample (ages 60 to 69 years) is 539 m. The steeper incline of the intervention group line, particularly between discharge
to home and 3-month post–ICU discharge study visit, indicates a greater rate of improvement in Six-Minute Walk Test (6MWT) distance.
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ercise capacity level equivalent to population norms.
However, exploratory analyses demonstrated an in-
creased rate of improvement in 6MWT results for the
intervention group and differences greater than MCID
from first assessment to 3- and 12-month follow-up.
There were no differences found for HRQoL or other
secondary outcomes.
Our patient characteristics compare well with those
described in other work undertaken with general ICU
patients [8,9]. Their conditions were less acute than
some [7], and they were older than many of the patients
with acute lung injury reported elsewhere [23,24]. With
results similar to those of the current study, Elliott et al.
did not find significant differences in 6MWT or HRQoL
at 8 or 26 weeks after discharge in a similar population
(APACHE II (20 vs 20), mechanical ventilation hours(101 vs 83 h) and age (60 v 57 yr)) [10]. This trial inter-
vention consisted solely of an outpatient home-based
program. Previous randomized controlled trials (RCTs)
conducted in the United States [9] and Belgium [7]
reported beneficial outcomes at hospital discharge from
therapy-led rehabilitation; however, no previous RCT
followed up participants for 12 months. The HRQoL do-
mains of the SF-36v2 remained lower than population
norms up to 12 months, again consistent with other tri-
als and longitudinal follow-up data, and physical func-
tion domains were worst affected [10,24-26].
Rehabilitation standards of care vary internationally.
This is illustrated well when comparing the results of
our study to those of others [9,27,28]. Our usual care in-
volved physiotherapy 7 days per week for 12 hours per
day and included early mobilization practices (sitting out
of bed, marching on the spot), but not mobilization
Table 5 Rate-of-change results for Six-Minute Walk Test






(−67.32 to 8.11) (−2.53 to 11.35)
Time 12.12 −1.23
(10.05 to 14.20)** (−1.62 to −0.85)**
Quad time −0.16 0.020
(−0.20 to −0.13)** (0.013 to 0.027)**
Group × time 2.95 −0.20
(0.016 to 5.88)** (−0.41 to 0.018)
Group × quad time −0.044
(−0.098 to 0.010)
a6MWT, Six-Minute Walk Test; TUG, Timed Up and Go Test. Time represents
the average number of weeks since first assessment (ICU discharge or ward
arrival). Variance components are available from the authors. Time represents
the change over time from first assessment in both groups. A positive value
represents an increased score (6MWT distance increase – improved function),
negative values represent decreased scores (TUG time decrease – improved
function). Quad time represents the rate of change between time points of
measurement. Group × time represents the treatment effect in this analysis:
the interaction between group and time. Compared to the control group, the
intervention group 6MWT distance improved by an average of 2.95 m/wk.
Group × quad time represents the interaction between rate of change and
group. **Significant results.
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patients at our center reported that 52% of patients mo-
bilized in the ICU [12]. This is more usual care physio-
therapy than reported in North American studies, where
only 12.5% of patients received any physical therapy inTable 6 Outcome measure mean change from first assessmen
Usual care
Outcome measure Time point n Mean change ES* n
6MWT (m) 3 months 49 184.25 1.67 47
12 months 35 219.49 1.98 40
TUG (s) 3 months 51 −23.37 0.55 50
12 months 38 −19.52 0.47 44
AQoL utility 3 months 53 −0.08 0.27 43
12 months 48 −0.11 0.36 40
SF-36v2 PF 3 months 45 −3.2 0.24 39
12 months 35 0.39 0.03 33
PCS 3 months 45 −2.26 0.19 38
12 months 35 3.33 0.28 32
MCS 3 months 44 3.12 0.24 38
12 months 35 2.59 0.19 32
a6MWT, Six-Minute Walk Test distance (meters); AQoL, Assessment of Quality of Life
groups occur when CI does not cross 0; ES, effect size; MCS, SF-36v2 Mental Compo
Function domain; SF-36v2, Short Form 36 Health Survey, version 2; TUG, Timed Up
standard deviation at first assessment. A positive mean change reflects improveme
assessments excluded). **ES, effect size = (intervention mean change – usual care m
reflects intervention advantage in terms of overall improvement.the ICU in the study by Morris and colleagues [27].
Pohlman and colleagues reported that 63% of partici-
pants in their intervention arm, who were not mechanic-
ally ventilated, were mobilized in the ICU; but none
received mobility exercises while ventilated in their
usual-care group [9,29]. Although our usual care did not
include walking away from the bed during MV, as yet
there is no evidence that this achieves improved out-
comes compared with marching on the spot next to the
bed or other functional mobility exercises. These differ-
ences in usual care practices may contribute to the lack
of separation between our groups compared with others
[9,27]. Furthermore, examining outcomes after hospital
discharge demonstrates that 53% of patients in the
usual-care group and 59% in the intervention group
were discharged to home in our trial. This compares
with 24% of usual-care patients and 43% of intervention
patients in the study by Schweickert et al. [9]. This
clearly highlights that, despite similar patient demo-
graphics in the two trials, a higher percentage of patients
in both of our groups went home. Also, they may reflect
differing health system practices between countries
where referral systems and nurse- and physiotherapist-to
-patient ratios differ [30], leading to difficulty in compar-
ing data internationally. European physiotherapy models
are more similar to those of Australasia [31], but to date
only one trial from Belgium has been reported [7], and it
recruited patients with higher acuity and longer ICU stay
with follow-up to hospital discharge.
The 12-month 6MWT values reached only 60% to
65% of normal population values and were consistentt and effect sizea
Intervention Difference
Mean change ES Difference 95% CI ES**
247.93 3.59 63.67 14.17 to 113.18+ 0.53
292.04 4.40 72.55 9.29 to 135.81+ 0.54
−31.68 0.72 −8.31 −24.90 to 8.28 0.20
−29.09 0.69 −9.57 −27.42 to 8.28 0.24
0.037 0.15 0.12 −0.03 to 0.26 0.33
0.031 0.12 0.14 –-.03 to 0.31 0.36
3.64 0.24 6.8 1.2 to 12.5+ 0.53
3.88 0.27 3.5 −3.5 to 10.5 0.25
3.33 0.26 5.6 0.09 to 11.1+ 0.45
6.46 0.49 3.1 −3.2 to 9.5 0.25
5.56 0.41 2.4 −3.6 to 8.5 0.18
7.50 0.57 4.9 −2.7 to 12.5 0.32
Measure score; CI, confidence interval: +significant differences between
nent score; PCS, SF-36v2 Physical Component score; PF, SF-36v2 Physical
and Go Test (seconds). *ES, effect size = mean change from first assessment/
nt at follow-up assessment relative to baseline (participants with missing
ean change)/pooled standard deviation for change. A positive difference
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able to measure premorbid 6MWT and that many ICU
survivors have chronic disease in addition to their pre-
senting diagnoses [23], it is likely that their premorbid
function starts lower than population norms and there-
fore remains low at follow-up. Because of this factor, it
may be preferable in the future to include age and co-
morbid disease as stratification variables. As this area of
clinical interest has developed in the past 6 years, the in-
fluence of these factors is clearer today than in 2007,
when we designed our trial and determined our strata.
We decided a priori to measure differences in 6MWT
at each time point [11]; however, evaluating the gains in
6MWT over time from the ICU may be a preferable hy-
pothesis. The fact that both groups improved from base-
line in most outcome measures suggests that our
exploratory analyses of measuring the rate of improve-
ment in 6MWT and the mean differences gained across
time in each group provide interesting and valuable in-
formation about the trajectory and timing of improve-
ment. Figure 2 and Table 3 demonstrate the comparative
improvement in the intervention group between dis-
charge to home and the 3-month time point in 6MWT.
The intervention group 6MWT started lower, which we
hypothesize may be the result of increased MV hours,
LOS and diagnosis of ICUAW being somewhat worse in
this group (Table 2). Although these data alone were not
individually significant, they may together represent a
sicker population. The effects of providing exercise over
this time frame of recovery can be cumulative [32]. Fur-
thermore, achievement of the MCID in an outcome such
as the 6MWT can be compared using this design. Issues
in calculating and applying the MCID have been
highlighted [33], but this measure does allow a clinical
benefit to be compared rather than relying solely on in-
ferential analyses. The 6MWT MCID has not yet been
published specifically for survivors of critical care. With-
out more detailed evidence defining the trajectory of
physical function recovery, it is difficult to hypothesize
about the shape and slope of the recovery graph over
time. If we believe this to be a smooth recovery toward
the premorbid slope as described by Iwashyna’s “big hit”
theory [34], then the triple-phase exercise intervention
we applied in this study resulted in the treatment group
reaching their peak recovery more quickly. This has im-
plications for return to the highest levels of function and
immersion in daily activities, including return to work. It
may also be relevant to the timing of study functional
impairment end points in future research.
What are the lessons to be drawn from this trial? This
patient group is a difficult, heterogeneous population to
study. Figure 1 attests to this, with high numbers of pa-
tients who were unable to be recruited. In most situa-
tions, next of kin were approached first, and consentwas difficult to obtain because their consideration for
their sick loved ones was paramount; thus making deci-
sions on their behalf regarding exercise and research
was difficult [35]. The failure to reach our enrollment
targets makes our negative results difficult to interpret.
The fact that we had available only data at ICU dis-
charge for sample calculations in 2007 contributed to
this problem. The variability in our primary outcome of
6MWT at hospital discharge was 125 m, but at 12
months it was 153 m. This variability increases the sam-
ple needed for separation at 12 months. Our outpatient
attendance was 41%, raising questions whether our lack
of response was a result of inadequate delivery of the
intervention. Although we did not include specific quali-
tative analyses, we hypothesize that the sample hetero-
geneity, including age and comorbid disease, may have
affected outpatient physiotherapy attendance. Younger
participants and those without a sepsis diagnosis
(Additional file 4) were unable or unwilling to return
to outpatient classes. Had we designed a more flexible
outpatient program that could be performed locally in
a community setting or in the home rather than one
that required a return to hospital outpatients, delivery
of the intervention may have improved. Additionally,
targeting only those participants with impairments on
repeat testing may have yielded different results. Al-
though similar to attendance at outpatient rehabilita-
tion by patients with chronic obstructive pulmonary
disease [36-39], we did not provide maintenance exercise
support up to 12 months as recommended in pulmonary
rehabilitation guidelines [40]. Given the number of partici-
pants with persistent functional impairments at 12
months, this may have improved responses to our inter-
vention. It is possible that the combination of high levels
of usual-care physiotherapy, sample size and inability to
provide the intervention in all participants or for only
those with impairments contributed to lack of significant
between-group differences. Furthermore, restricting re-
cruitment to a more homogeneous population as defined
by age groups, comorbidities, sepsis and diagnosis groups
may reduce sample size requirements in future trials.
Given the results reported by Burtin et al. [7], it is also
possible that patients with a longer ICU stay may benefit
more from exercise intervention, although this needs to
be tested with inclusion of longer follow-up measures. In-
deed, the subgroup of patients still ventilated at day 5 after
ICU admission had a more than twofold increase in diag-
nosis of ICUAW in our study. It may be these patients
who need to be targeted for early rehabilitation. However,
more evidence for the direct relationship between muscle
strength and functional impairment is warranted. We did
not test for delirium or any cognitive or psychological se-
quelae of ICU admission. Recent research has demon-
strated these to be common and important impairments
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physical and cognitive interventions in rehabilitation is
warranted [42].
Recent research highlights the importance of func-
tional outcomes to ICU survivors [43,44]; however, the
type, quantity, timing and length of rehabilitation inter-
vention needed are not yet established [45]. The variabil-
ity across time in the 6MWT highlights a need for
identification of more sensitive and specific objective
outcome measures or a “package” of measures to be de-
veloped in this population. More than one measure may
be required to measure different activity limitations and
disability at different time points of recovery. Using
HRQoL measures that report on participation may not
be interchangeable with those measuring activity restric-
tion, such as performance-based tests like the 6MWT
[46]. Although our trial was well-conducted, adhered to
protocol, attempted long-term follow-up, maintained
(single) blinding and scrutinized all available data using
intention-to-treat and linear mixed models, it was a
single-center study, which limits the generalizability of
our findings.
Future research that examines very early rehabilitation
in the ICU, such as cycling exercise [12], that seeks to
identify patients at risk for worse muscle weakness and
the benefits of including more ward-based intervention
[47] are warranted. Furthermore, studies that include
measurements of participant self-efficacy and resilience
as well as caregiver attributes and support will also be
important, as these factors may impact outcomes. In-
deed, it is possible that these less tangible and unmeas-
ured factors may have influenced between-group
differences in our study.
Conclusion
In this single-center RCT measuring therapist-led exer-
cise rehabilitation in three phases from ICU though to
outpatient classes, physical function recovery as mea-
sured by the 6MWT at 12 months was not different be-
tween usual-care and intervention cohorts. Furthermore,
HRQoL was not different between groups at any time
point after randomization.
Key messages
 This single-center RCT shows that physical function
measured using the 6MWT was not significantly
different between intervention and usual-care
groups at 12-month follow-up in an Australian ICU
population.
 HRQoL was not significantly different between
groups.
 The rate of improvement for the 6MWT was
significantly better in the intervention group basedon exploratory analysis. This outcome warrants
further investigation.
 The data presented in this paper will be useful for
the design of future trials in this area.
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